Literature DB >> 23368530

Association between genetic variants of DNA repair genes and coronary artery disease.

Cahide Gokkusu1, Bedia Cakmakoglu, Selcuk Dasdemir, Feti Tulubas, Ali Elitok, Sule Tamer, Sule Seckin, Berrin Umman.   

Abstract

Polymorphisms in DNA repair genes may be associated with differences in the repair efficiency of DNA damage and may influence an individual's risk of atherosclerosis. Genetic research on coronary artery disease (CAD) has traditionally focused on investigation aimed at identifying disease-susceptibility genes. The aim of this study was to investigate the relationship between AP-endonuclease-1 (Asp148Glu), XRCC1 (Arg399Gln), XRCC3 (Thr241Met), XPD (Lys751Gln), XPG (Asp1104His), and hOGG1 (Ser326Cys), gene polymorphisms and the risk of developing CAD in a Turkish population. The study population consisted of 197 patients with acute coronary syndrome (ACS) with chronic CAD and 135 healthy subjects' age and sex matched. Gene polymorphisms were determined by the polymerase chain reaction-restriction fragment length polymorphism method. We demonstrated for the first time, a positive association of XRCC3 and hOGG1 DNA repair gene variants with CAD risk. XRCC3 Thr/Thr genotype and Thr allele frequencies were significantly increased in ACS and chronic CAD patients compared with the control group (p<0.05). It was also observed that there is a protective role of XRCC3 Met alleles against both ACS and chronic CAD (p<0.05). hOGG1 Cys alleles were found significantly higher in ACS patients than in the control group and carriers of the Cys allele had a 1.7-fold increased risk for ACS. In addition, we confirmed the association of XRCC3 Thr241Met and hOGG1 Ser326Cys gene variants with CAD by haplotype analysis. We found that CAD risk is associated with XRCC3 Thr: hOGG1 Cys haplotype, whereas XRCC3 Met: hOGG1 Ser haplotype was found to be protective against the disease. The preliminary results suggested that XRCC3 and hOGG1 genetic variants may be risk factors by affecting the enzyme's function that may lead to development of CAD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23368530     DOI: 10.1089/gtmb.2012.0383

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

Review 1.  Association between the 8-oxoguanine DNA glycosylase gene Ser326Cys polymorphism and age-related cataract: a systematic review and meta-analysis.

Authors:  Xiao-Cui Liu; Xiao-Hui Guo; Bing Chen; Zhao-Hui Li; Xiao-Fei Liu
Journal:  Int Ophthalmol       Date:  2017-06-19       Impact factor: 2.031

2.  Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.

Authors:  Wen-Qi Ma; Xi-Qiong Han; Xin Wang; Ying Wang; Yi Zhu; Nai-Feng Liu
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

3.  Darwinism for the Genomic Age: Connecting Mutation to Diversification.

Authors:  Xia Hua; Lindell Bromham
Journal:  Front Genet       Date:  2017-02-07       Impact factor: 4.599

4.  Complex interplay of DNA damage, DNA repair genes, and oxidative stress in coronary artery disease.

Authors:  Elena Vakonaki; Konstantinos Tsarouhas; Demetrios A Spandidos; Aristidis M Tsatsakis
Journal:  Anatol J Cardiol       Date:  2016-12       Impact factor: 1.596

5.  Common polymorphisms of the hOGG1, APE1 and XRCC1 genes correlate with the susceptibility and clinicopathological features of primary angle-closure glaucoma.

Authors:  Kun Zeng; Bo Zhong; Min Fang; Xiao-Li Shen; Li-Na Huang
Journal:  Biosci Rep       Date:  2017-05-17       Impact factor: 3.840

Review 6.  APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions.

Authors:  Shweta Thakur; Bibekananda Sarkar; Ravi P Cholia; Nandini Gautam; Monisha Dhiman; Anil K Mantha
Journal:  Exp Mol Med       Date:  2014-07-18       Impact factor: 8.718

7.  The role of oxidative DNA damage and GSTM1, GSTT1, and hOGG1 gene polymorphisms in coronary artery disease risk.

Authors:  Ela Kadıoğlu; Gülten Taçoy; Eren Özçağlı; Kaan Okyay; Mehmet K Akboğa; Atiye Çengel; Semra Şardaş
Journal:  Anatol J Cardiol       Date:  2016-04-26       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.